Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIO
2626
DELISTED
City Office REIT
CIO
| $1.98M | ﹤0.01% |
324,370
+4,943
| +2% | +$23K |
|
2627
SES AI
SES
$212M
| $1.98M | ﹤0.01% |
1,080,283
-5,969
| -0.5% | -$12.9K |
|
|
AGS
2628
DELISTED
PlayAGS
AGS
| $1.97M | ﹤0.01% |
233,588
+13,148
| +6% | +$97.3K |
|
2629
Holley
HLLY
$384M
| $1.97M | ﹤0.01% |
403,788
+5,147
| +1% | +$22.7K |
|
2630
RUM Group Inc
RUM
$3.74B
| $1.96M | ﹤0.01% |
436,896
+24,032
| +6% | +$117K |
|
2631
Stellantis
STLA
$20.2B
| $1.96M | ﹤0.01% |
83,852
+27,107
| +48% | +$560K |
|
2632
PubMatic
PUBM
$783M
| $1.95M | ﹤0.01% |
119,352
+160
| +0.1% | +$2.32K |
|
2633
Patria Investments
PAX
$1.79B
| $1.94M | ﹤0.01% |
125,367
-62
| -0% | -$880 |
|
2634
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
| $1.94M | ﹤0.01% |
17,597
-1,299
| -7% | -$143K |
|
2635
EverCommerce
EVCM
$1.76B
| $1.93M | ﹤0.01% |
174,953
-938
| -0.5% | -$9.04K |
|
2636
HighPeak Energy
HPK
$912M
| $1.92M | ﹤0.01% |
134,527
+15,026
| +13% | +$238K |
|
|
SRG
2637
Seritage Growth Properties
SRG
$131M
| $1.91M | ﹤0.01% |
204,630
+19,469
| +11% | +$164K |
|
2638
MediaAlpha
MAX
$787M
| $1.91M | ﹤0.01% |
171,265
+4,777
| +3% | +$47.3K |
|
2639
HCI Group
HCI
$2.28B
| $1.9M | ﹤0.01% |
21,731
+1,375
| +7% | +$101K |
|
2640
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $1.9M | ﹤0.01% |
208,132
+67,012
| +47% | +$576K |
|
2641
Futu Holdings
FUTU
$14.7B
| $1.89M | ﹤0.01% |
34,666
-3,011
| -8% | -$171K |
|
2642
SkinHealth Systems
SKIN
$84.2M
| $1.87M | ﹤0.01% |
600,696
-42,326
| -7% | -$159K |
|
2643
AB InBev
BUD
$156B
| $1.86M | ﹤0.01% |
28,723
+6,722
| +31% | +$397K |
|
|
SLRN
2644
DELISTED
ACELYRIN
SLRN
| $1.85M | ﹤0.01% |
247,756
+3,934
| +2% | +$33.6K |
|
2645
Arcutis Biotherapeutics
ARQT
$3.3B
| $1.85M | ﹤0.01% |
571,318
+187,505
| +49% | +$510K |
|
2646
El Pollo Loco
LOCO
$463M
| $1.83M | ﹤0.01% |
207,675
+2,649
| +1% | +$22.8K |
|
2647
Outset Medical
OM
$84.6M
| $1.83M | ﹤0.01% |
22,572
-2,919
| -11% | -$238K |
|
2648
Sumitomo Mitsui Financial
SMFG
$166B
| $1.82M | ﹤0.01% |
188,240
+36,170
| +24% | +$351K |
|
2649
EyePoint Inc
EYPT
$1.17B
| $1.81M | ﹤0.01% |
78,410
+6,862
| +10% | +$76.7K |
|
2650
Ranpak Holdings
PACK
$464M
| $1.81M | ﹤0.01% |
311,253
+138
| +0% | +$583 |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.